You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

15-161

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for

Not yet recruiting
  • Primary Hepatocellular Carcinoma
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • camrelizumab for Injection
  • (no location specified)
Nov 13, 2023

Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))

Recruiting
  • Sarcoma
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
  • Beijing, China
    Peking University People's Hospital
Nov 6, 2023

Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab

Recruiting
  • Metastatic Gastric Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Nivolumab Injection
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Aug 23, 2023

Advanced Pancreatic Cancer Trial in Hangzhou (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) in

Recruiting
  • Advanced Pancreatic Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) in combination with Nivolumab
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Mar 8, 2022

Primary Liver Cancer Trial in Hangzhou (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)))

Recruiting
  • Primary Liver Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Apr 21, 2021

Advanced Malignant Solid Tumor Trial in ShangHai (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)))

Recruiting
  • Advanced Malignant Solid Tumor
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • ShangHai, Shanghai, China
  • +1 more
Apr 26, 2021

Chronic Kidney Disease to Assess Treatment Experience and

Active, not recruiting
  • Chronic Kidney Disease
    • Riverside, California
    • +46 more
    Jan 16, 2023

    Chronic Lymphocytic Leukemia, Hypogammaglobulinemia Trial in Worldwide (Panzyga, Placebo)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Hypogammaglobulinemia
    • Panzyga
    • Placebo
    • Saint Petersburg, Florida
    • +52 more
    Aug 10, 2022

    Psoriasis Trial in Worldwide (PF-06826647 or Placebo, PF-06826647)

    Completed
    Has Results
    • Psoriasis
    • Phoenix, Arizona
    • +44 more
    Aug 25, 2021

    Epilepsy Trial in Worldwide (Lacosamide Tablet, Lacosamide Oral Solution)

    Active, not recruiting
    • Epilepsy
    • Lacosamide Tablet
    • Lacosamide Oral Solution
    • Little Rock, Arkansas
    • +86 more
    Jan 3, 2023

    Crohn Disease Trial in Worldwide (RHB-104 (fixed-dose combination: 95 mg clarithromycin, 45 mg rifabutin, and 10 mg

    Completed
    Has Results
    • Crohn Disease
    • RHB-104 (fixed-dose combination: 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine)
    • San Carlos, California
    • +23 more
    Feb 7, 2021

    Crohn's Disease Trial in Worldwide (Guselkumab, Placebo)

    Not yet recruiting
    • Crohn's Disease
    • Phoenix, Arizona
    • +82 more
    Jun 20, 2023

    Acute Ischemic Stroke Trial in Bunkyo-ku (JTR-161, Placebo)

    Completed
    • Acute Ischemic Stroke
    • JTR-161
    • Placebo
    • Bunkyo-ku, Tokyo, Japan
      Nippon Medical School Hospital
    Jun 28, 2022

    Tardive Dyskinesia Trial in Worldwide (SD-809, Placebo)

    Completed
    Has Results
    • Tardive Dyskinesia
    • Tuscaloosa, Alabama
    • +81 more
    Mar 31, 2022

    Dry Eye Disease Trial in Lakeway (K-161, Placebo)

    Recruiting
    • Dry Eye Disease
    • Birmingham, Alabama
    • +50 more
    Jan 17, 2023

    HIV Trial in New York (Youth Health SMS)

    Not yet recruiting
    • HIV Infections
    • Youth Health SMS
    • New York, New York
      New York State Psychiatric Institute
    Jul 30, 2022

    MDD, Treatment-Resistant Depression, Depression Trial run by the NIMH (Placebo, TS-161 (50 - 100 mg))

    Recruiting
    • Major Depressive Disorder
    • +2 more
    • Placebo
    • TS-161 (50 - 100 mg)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)

    Not yet recruiting
    • Advanced or Metastatic Solid Tumors
    • +4 more
    • Houston, Texas
      MD Anderson
    Mar 27, 2023

    Personalised Disease Monitoring in Metastatic Breast Cancer

    Recruiting
    • Breast Cancer Metastatic
    • Estrogen Receptor-positive Breast Cancer
      • Gothenburg, Sweden
      • +6 more
      Dec 7, 2022

      Chronic Pain, Exposure, Adolescent Behavior Trial in Menlo Park (Graded exposure treatment (GET))

      Recruiting
      • Chronic Pain
      • +3 more
      • Graded exposure treatment (GET)
      • Menlo Park, California
        Pediatric Pain Management Clinic
      Jul 27, 2022

      Pancreatic Necrosis, Pancreatitis, Acute Necrotizing Trial in Hvidovre (Direct Endoscopic Necrosectomy, Step-up Approach)

      Recruiting
      • Pancreatic Necrosis
      • Pancreatitis, Acute Necrotizing
      • Direct Endoscopic Necrosectomy
      • Step-up Approach
      • Hvidovre, Denmark
        Copenhagen University Hospital, Hvidovre
      Nov 2, 2022

      HIV/AIDS Trial in New York (Infographic Intervention, Paper-based HIV self-testing information)

      Completed
      Has Results
      • HIV/AIDS
      • Infographic Intervention
      • Paper-based HIV self-testing information
      • New York, New York
        New York University Rory Meyers College of Nursing
      Oct 25, 2022

      Tardive Dyskinesia Trial in Worldwide (SD-809, Placebo)

      Completed
      Has Results
      • Tardive Dyskinesia
      • Tuscaloosa, Alabama
      • +105 more
      Nov 5, 2021

      Epilepsy Trial in Worldwide (USL261)

      Terminated
      Has Results
      • Epilepsy
      • Phoenix, Arizona
      • +57 more
      Jan 19, 2023

      Diabetes, Type 2 Trial in Salamanca (Vibration exercise)

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • Vibration exercise
      • Salamanca, Spain
        University of Salamanca
      Jul 21, 2023